Australia to consider a batch of OTC switches

31 December 2019 - Deborah Wilkes

Premium

Australia's Advisory Committee on Medicines Scheduling (ACMS) will consider applications to switch several medicines – adapalene, ondansetron, rizatriptan and melatonin – from pre-scription to non-prescription status at its next meeting in March 2020.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: